Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

CANCER THERAPY

Liver metastases inhibit immunotherapy efficacy

Liver metastases lead to resistance to immunotherapy through the ‘siphoning’ of tumor antigen–specific CD8+ T cells into the liver, which results in a systemic ‘immune desert’ incapable of controlling tumor burden.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Proposed mechanism by which liver metastases result in resistance to immunotherapy.

References

  1. 1.

    Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Cell 168, 707–723 (2017).

    CAS  Article  Google Scholar 

  2. 2.

    Yu, J. et al. Nat. Med. https://doi.org/10.1038/s41591-020-1131-x (2020).

  3. 3.

    Forrester, J. V., Xu, H., Lambe, T. & Cornall, R. Mucosal Immunol. 1, 372–381 (2008).

    CAS  Article  Google Scholar 

  4. 4.

    Medina-Echeverz, J., Eggert, T., Han, M. & Greten, T. F. Cancer Immunol. Immunother. 64, 931–940 (2015).

    CAS  Article  Google Scholar 

  5. 5.

    Qian, B. Z. & Pollard, J. W. Cell 141, 39–51 (2010).

    CAS  Article  Google Scholar 

  6. 6.

    Twyman-Saint Victor, C. et al. Nature 520, 373–377 (2015).

    CAS  Article  Google Scholar 

  7. 7.

    Lee, J. C. et al. Sci. Immunol. 5, eaba0759 (2020).

    CAS  Article  Google Scholar 

  8. 8.

    Finn, R. S. et al. N. Engl. J. Med. 382, 1894–1905 (2020).

    CAS  Article  Google Scholar 

  9. 9.

    Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Nat. Rev. Clin. Oncol. 14, 399–416 (2017).

    CAS  Article  Google Scholar 

  10. 10.

    Villanueva, A. N. Engl. J. Med. 380, 1450–1462 (2019).

    CAS  Article  Google Scholar 

  11. 11.

    Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E. & Heikenwalder, M. Nat. Immunol. 19, 222–232 (2018).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Amaia Lujambio.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lindblad, K.E., Lujambio, A. Liver metastases inhibit immunotherapy efficacy. Nat Med 27, 25–27 (2021). https://doi.org/10.1038/s41591-020-01190-9

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing